Finance

Beta
Lists
VVOS:NASDAQ
Vivos Therapeutics Inc
$0.45
-9.05%
(-0.045) 1D
$0.45
+0.18% (+0.00080)
After hours
Closed: Jul 2, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VVOS...
Open
$0.48
High
$0.51
Low
$0.44
Mkt. cap
6.28M
Avg. vol.
3.23M
Volume
400.62K
52-wk high
$7.95
52-wk low
$0.38
EPS
-$2.12
Beta
6.16
Shares outstanding
13.90M
No. of employees
270
Open
$0.48
High
$0.51
Low
$0.44
Mkt. cap
6.28M
Avg. vol.
3.23M
Volume
400.62K
52-wk high
$7.95
52-wk low
$0.38
EPS
-$2.12
Beta
6.16
Shares outstanding
13.90M
No. of employees
270
News stories
From sources across the web
About Vivos Therapeutics Inc
CEO-
Employees270
Founded2016
HeadquartersLittleton, Colorado, United States
SectorHealth care provider
Websitevivos.com
Analyst ratings
Based on 3 analysts giving stock ratings to VVOS in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for VVOS in the last 3 months.
Highest
Current $0.45
$3.10 (+584.02%)
Average
$2.45 (+440.60%)
Lowest
$1.75 (+286.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lucas Ward
Ascendiant
Buy
Reiterated
$3.10
+584%
06/04/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$2.50
+451.6%
04/17/2026
Scott Henry
Alliance Global Partners
Hold
Maintained
$1.75
+286.1%
04/17/2026
Unknown Analyst
Alliance Global Partners
Hold
Maintained
$2.50
+451.6%
01/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.82M
6.78M
3.82M
5.14M
Cost of goods sold
1.71M
2.85M
836.00K
2.08M
Cost of revenue
1.71M
2.85M
836.00K
2.08M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.67M
8.29M
8.93M
9.22M
Operating expense
6.98M
8.67M
9.37M
9.67M
Total operating expenses
8.68M
11.52M
10.21M
11.76M
Operating income
-4.86M
-4.73M
-6.38M
-6.62M
Other non operating income
-148.00K
-666.00K
-572.00K
-1.14M
EBT including unusual items
-5.01M
-5.40M
-6.95M
-7.75M
EBT excluding unusual items
-5.01M
-5.40M
-6.95M
-7.75M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.01M
-5.40M
-6.89M
-7.68M
Net profit margin
-131.23%
-79.61%
-180.28%
-149.43%
Earnings per share
-0.55
-0.49
-0.58
-0.52
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
306.00K
384.00K
442.00K
454.00K
EBITDA
-4.56M
-4.35M
-5.94M
-6.16M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer